Stockreport

Israel's SciSparc reports promising Phase 2 data for Alzheimer's agitation drug [Seeking Alpha]

SciSparc Ltd.  (SPRC) 
PDF Israel's SciSparc reports promising Phase 2 data for Alzheimer's agitation drugJun. 02, 2023 1:28 PM ETSciSparc Ltd. (SPRC)By:Val KennedySA EditorjuststockIsraeli biote [Read more]